Devyser HBOC NGS is a fast and robust NGS solution aimed at the detection of germline variants in 12 genes associated with an increased risk of hereditary breast and ovarian cancer: ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and copy number variations (CNVs).
Key Features
Clinical Applications
The panel is intended to identify variants in 12 genes implicated in the risk of developing breast and/or ovarian cancer: ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, and TP53.
Intended Audience / User
Ideal for laboratories focused on the targeted analysis of genes related to breast and/or ovarian cancer predisposition.
Benefits
Ordering Information
CE-IVD Marked
| 8-A111-24 | 24 tests. |
| 8-A111-48 | 48 tests. |
RUO Marked
| 8-A111-24-RUO | 24 tests. |
| 8-A111-48-RUO | 48 tests. |
Additional Reagents
| 8-A204 | Devyser Library Clean |








